BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 6343861)

  • 1. Acyclovir halts progression of herpes zoster in immunocompromised patients.
    Balfour HH; Bean B; Laskin OL; Ambinder RF; Meyers JD; Wade JC; Zaia JA; Aeppli D; Kirk LE; Segreti AC; Keeney RE
    N Engl J Med; 1983 Jun; 308(24):1448-53. PubMed ID: 6343861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster.
    Wood MJ; Johnson RW; McKendrick MW; Taylor J; Mandal BK; Crooks J
    N Engl J Med; 1994 Mar; 330(13):896-900. PubMed ID: 8114860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical aspects of chickenpox and herpes zoster.
    Balfour HH
    J Int Med Res; 1994; 22 Suppl 1():3A-12A; discussion 12A-13A. PubMed ID: 8063022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Varicella-zoster virus infections in the immunosuppressed child. Treatment with Acyclovir and controls].
    Peyramond D; Denoyel GA; Philip T; Souillet G; Philippe N; Bertrand JL; Bertoye A
    Arch Fr Pediatr; 1983 Feb; 40(2):95-9. PubMed ID: 6347116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy of herpes zoster with oral acyclovir.
    Huff JC; Bean B; Balfour HH; Laskin OL; Connor JD; Corey L; Bryson YJ; McGuirt P
    Am J Med; 1988 Aug; 85(2A):84-9. PubMed ID: 3044099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of oral acyclovir treatment of acute herpes zoster.
    Wood MJ; Ogan PH; McKendrick MW; Care CD; McGill JI; Webb EM
    Am J Med; 1988 Aug; 85(2A):79-83. PubMed ID: 3044098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of herpes zoster in patients by long-term oral acyclovir after allogeneic bone marrow transplantation.
    Perren TJ; Powles RL; Easton D; Stolle K; Selby PJ
    Am J Med; 1988 Aug; 85(2A):99-101. PubMed ID: 3044103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind study comparing 2 dosages of valacyclovir hydrochloride for the treatment of uncomplicated herpes zoster in immunocompromised patients 18 years of age and older.
    Arora A; Mendoza N; Brantley J; Yates B; Dix L; Tyring S
    J Infect Dis; 2008 May; 197(9):1289-95. PubMed ID: 18422441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Acyclovir therapy of varicella-zoster virus infections in the immunosuppressed children ].
    Peyramond D; Denoyel GA; Bertrand JL; Bertoye A
    Pathol Biol (Paris); 1982 Jun; 30(6 Pt 2):596-602. PubMed ID: 6750532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acyclovir therapy in varicella/zoster diseases in immunocompromised children with cancer].
    Kuhn N; Landbeck G
    Monatsschr Kinderheilkd; 1984 Feb; 132(2):105-9. PubMed ID: 6328285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral acyclovir in the treatment of herpes zoster in general practice.
    Morton P; Thomson AN
    N Z Med J; 1989 Mar; 102(863):93-5. PubMed ID: 2648213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A controlled trial of acyclovir for chickenpox in normal children.
    Dunkle LM; Arvin AM; Whitley RJ; Rotbart HA; Feder HM; Feldman S; Gershon AA; Levy ML; Hayden GF; McGuirt PV
    N Engl J Med; 1991 Nov; 325(22):1539-44. PubMed ID: 1944438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study of the efficacy and safety of valaciclovir versus acyclovir in the treatment of herpes zoster.
    Lin WR; Lin HH; Lee SS; Tsai HC; Huang CK; Wann SR; Chen YS; Chiang SC; Yen MY; Liu YC
    J Microbiol Immunol Infect; 2001 Jun; 34(2):138-42. PubMed ID: 11456360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and risk of postherpetic neuralgia after varicella zoster virus infection in hematopoietic cell transplantation recipients: Hokkaido Hematology Study Group.
    Onozawa M; Hashino S; Haseyama Y; Hirayama Y; Iizuka S; Ishida T; Kaneda M; Kobayashi H; Kobayashi R; Koda K; Kurosawa M; Masauji N; Matsunaga T; Mori A; Mukai M; Nishio M; Noto S; Ota S; Sakai H; Suzuki N; Takahashi T; Tanaka J; Torimoto Y; Yoshida M; Fukuhara T
    Biol Blood Marrow Transplant; 2009 Jun; 15(6):724-9. PubMed ID: 19450757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A topical solution of 40% idoxuridine in dimethyl sulfoxide compared to oral acyclovir in the treatment of herpes zoster. A double-blind multicenter clinical trial].
    Aliaga A; Armijo M; Camacho F; Castro A; Cruces M; Díaz JL; Fernández JM; Iglesias L; Ledo A; Mascaró JM
    Med Clin (Barc); 1992 Feb; 98(7):245-9. PubMed ID: 1560699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intravenous acyclovir (ACV, Zovirax) therapy of varicella zoster infections in immunologically endangered patients].
    Kerpel-Fronius S; Nyerges G; Mészner Z; Eckhardt S; Walker E; Bridgen D
    Orv Hetil; 1983 Nov; 124(48):2913-8. PubMed ID: 6657237
    [No Abstract]   [Full Text] [Related]  

  • 17. Acyclovir therapy of varicella-zoster virus infections in immunocompromised patients.
    Balfour HH; McMonigal KA; Bean B
    J Antimicrob Chemother; 1983 Sep; 12 Suppl B():169-79. PubMed ID: 6313596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of varicella-zoster virus infection in severely immunocompromised patients. A randomized comparison of acyclovir and vidarabine.
    Shepp DH; Dandliker PS; Meyers JD
    N Engl J Med; 1986 Jan; 314(4):208-12. PubMed ID: 3001523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current therapy of varicella zoster virus infection in immunocompromised patients. A comparison of acyclovir and vidarabine.
    Shepp DH; Dandliker PS; Meyers JD
    Am J Med; 1988 Aug; 85(2A):96-8. PubMed ID: 3044102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Varicella zoster meningoencephalitis following treatment for dermatomal zoster in an alloBMT patient.
    Tauro S; Toh V; Osman H; Mahendra P
    Bone Marrow Transplant; 2000 Oct; 26(7):795-6. PubMed ID: 11042663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.